2m 2m 2m 2m 2m 2m 2m
EVOLUS (EOLS)
NASDAQ
$8.40+$0.005 (+0.06%)
Price as of Aug 21, 2026 7:30 PM EDT- $554.2MMarket Cap
- 9.24%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
EVOLUS (EOLS)
$8.40+$0.005 (+0.06%)
EOLS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.39 | ||
Change | +$0.04 (+0.48%) | ||
Open | $8.35 | ||
High | $8.48 | ||
Low | $8.23 | ||
Previous Close | $8.35 | ||
Volume | 582,721 | ||
30-Day Average Volume | 956,031 | ||
1-Week Change | 2.88% | ||
1-Month Change | 44.53% | ||
1-Year Change | 9.24% | ||
3-Year Change | -10.74% | ||
5-Year Change | -22.60% | ||
Fundamentals | |||
Shares Outstanding | 66.1M | ||
Total Assets | $248.0M | ||
Market Cap | $554.2M | ||
Enterprise Value | $665.7M | ||
Period: QTR TTM FY | |||
Revenue | $83.3M | ||
Net Income | -$8.1M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$8.2M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | -113 | ||
Enterprise Value/Revenue | 8 | ||
P/B | -18 | ||
P/E | -70 | ||
PEG | -3 | ||
Price/Free Cash Flow | -152 | ||
Price/Operating Cash Flow | -154 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue